Lanthanum Carbonate Versus Calcium Carbonate for Vascular Abnormalities in Patients With Chronic Kidney Disease and Hyperphosphatemia
Phase of Trial: Phase IV
Latest Information Update: 03 Oct 2016
At a glance
- Drugs Lanthanum carbonate (Primary) ; Calcium carbonate
- Indications Hyperphosphataemia; Renal failure
- Focus Therapeutic Use
- Acronyms LAVALIER
- 07 Jun 2017 Biomarkers information updated
- 26 Sep 2016 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
- 20 Apr 2015 Status changed from not yet recruiting to recruiting as ClinicalTrials.gov record.